Kristine Harris Solomon

Kristine Harris Solomon has extensive experience in financial planning and analysis roles. Kristine is currently employed as the VP of Financial Planning & Analysis at Envision Pharma Group. Prior to this, they served as the Director of Corporate Financial Planning and Analysis at Indeed.com from January 2022 to March 2023. Before that, they worked as the Interim Director of FP&A at ATCC from October 2021 to January 2022. Kristine also held the position of Senior Director of Commercial Finance at Curia (formerly AMRI) from February 2021 to August 2021. From January 2018 to February 2021, they were the Head of Global Commercial Finance at Seqirus. Before joining Seqirus, they worked as the Senior Director of Financial Planning and Analysis at Intercept Pharmaceuticals from November 2015 to January 2018. Kristine's earlier roles include Senior Director of Finance at Stryker from March 2014 to February 2015 and Director of Financial Planning and Analysis at Actavis from December 2006 to April 2013. Kristine started their career at Quest Diagnostics, where they held various positions, including Director of Operations from March 2002 to December 2006 and Manager of Planning and Analysis from May 1997 to March 1999.

Kristine Harris Solomon completed their undergraduate education at Franklin & Marshall College from 1985 to 1989. Kristine earned a Bachelor of Arts (BA) degree in Accounting during this time.